Osteologix Inc. (OLGX) is Dedicated to Patient Care
Osteologix Inc. is a specialty biopharmaceutical company committed to improving the health of those afflicted with musculoskeletal diseases, such as osteoporosis. Their lead product candidate, NB S101, is a dual-acting bone agent for the treatment of osteoporosis. Osteologix trades on the OTCBB as part of the Diagnostic Substances industry. Their headquarters are in Glen Allen, Virginia. The company's commitment is to developing innovative pharmaceuticals for the treatment and prevention of diseases of the bones and joints. Osteologix works to collaborate with others in the healthcare community. These collaborations apply new scientific information and clinical data to the development of products…